Plain-English translation of NCT06081920 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with advanced melanoma—a serious skin cancer that has spread to other parts of the body or come back after initial treatment. Researchers want to learn whether this medication is safe to take and whether it helps slow or stop the cancer's growth.
Advanced melanoma is difficult to treat, especially after it has already been through standard treatments. This trial exists to see if this new medication might offer hope for patients whose cancer has progressed or returned, and to understand how well the treatment works and what side effects to expect.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive as your treatment and visit the study center regularly so doctors can monitor how well the medication is working and check for any side effects. The trial will track your tumor using scans and blood tests to see if the cancer is responding to treatment. Your exact schedule of visits and how long you'll be in the study will depend on how your cancer responds and any side effects you experience.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China